11 December 2017
Most vapers are still waiting for a long term study that would support the claims that e-liquids and vaping are much better for people than regular cigarettes. Now there is something we can actually show to the sceptics thanks to Dr Riccardo Polosa.
According to a study that was recently presented on the E-Cigarette Summit in London and published in the Nature journal, vapers that have never smoked regular cigarettes experience no apparent long-term negative health effects from vaping.
A research group led by Dr Riccardo Polosa measured coronary, respiratory and pulmonary vital signs in a group of young vapers with a 3.5 years vaping experience and no prior cigarette smoking history. A similar group of non-vapers, no smokers has tested as well as a control group.
Scientists took into consideration blood pressure, heart rate, exhaled carbon monoxide, high-resolution computed tomography (HRCT) of the lungs and many other aspects and found, that vaping had no negative health effects, it actually showed results to be identical to those of the non-smokers, non-vapers from the control group.
The results show no significant changes in lung function or structural abnormalities caused by daily exposure to electronic cigarettes. No changes in average heart rate or blood pressure were found even after 3.5 years of vaping – cigarette smokers show signs of lung damage after two years of smoking.
This is the first study showing long-term effects of vaping on people who have never smoked regular cigarettes and is great news for vapers and even better for cigarette smokers who now know that e-cigarettes are less harmful compared to regular cigarettes and a good way of smoking cessation despite the previous biased news stories.
Read full research article here: chemnovatic.com/Files/Health%20impact%20of%20E-cigarettes.pdf
The article was originally published at https://www.nature.com, research conducted by: Riccardo Polosa, Fabio Cibella, Pasquale Caponnetto, Marilena Maglia, Umberto Prosperini, Cristina Russo and Donald Tashkin.